MedPHA Bioscience Co., Ltd. is located in Guangdong-Macao In-Depth Cooperation Zone in Hengqin, Guangdong Province. It was co-founded by Austrian PhD returnees with distinguished academic background and profound industrial experience. The founding shareholders responsible for corporate operations management possess extensive multinational corporations experience in both management and innovation. We have assembled a core technical team of world-class R&D professionals.
MedPHA employs cutting-edge synthetic biology engineering technologies, focusing on independent innovation and the development of next-generation fully bio-based, naturally degradable PHA. We also specialize in the scaled production, application, and commercialization of the corresponding high-end downstream derivatives of PHA. Since 2019, we have achieved a comprehensive library of intellectual property rights and patents, which cover the entire industrial chain of new PHA materials - from microbial strains, fermentation processes, extraction and purification, to application development. Building on top of the comprehensive coverage of intellectual properties, our company continues to deepen its R&D capabilities by establishing a technology platform for advanced PHA application.
Upholding the corporate philosophy of technology-first, MedPHA's three product lines (Industrial-grade PHA, Medical-grade PHA and small molecule D3HB) are now among the world's leading ranks. PHA, being fully bio-based and completely biodegradable in all natural environments, are emerging as revolutionary green materials with tremendous market potential—perfectly aligning with health-conscious, micro-plastic free and low-carbon sustainability trends. Meanwhile, MedPHA's medical-grade PHA demonstrates exceptional biocompatibility and processability, driving increasing application in innovative absorbable medical devices. Developed through the same advanced PHA technology platform via starch glucose fermentation, our D3HB is gaining significant popularity among cognitive-intensive users for its unique brain health benefits.
Since the company's establishment, MedPHA has received relevant awards such as National High-tech Enterprise, Provincial Specialized and New Small and Medium-sized Enterprises, Guangdong Provincial Engineering Research Center for Biosynthesis, SME and Postdoctoral Workstation, Hengqin IPO Reserve Enterprise, Deloitte China Rising Star. The company has received several rounds of industrial funds and venture capitals. Having overcome the severe challenges posed by the pandemic in recent years, our company is thriving to become the global leading supplier of PHA solutions while aligning with China's green and health transition, as well as global sustainable development initiatives.
